Unknown

Dataset Information

0

S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.


ABSTRACT: Osteosarcoma (OS) is an aggressive and highly metastatic form of primary bone cancer affecting young children and adults. Previous studies have shown that hypomethylation of critical genes is driving metastasis. Here, we examine whether hypermethylation treatment can block OS growth and pulmonary metastasis. Human OS cells LM-7 and MG-63 were treated with the ubiquitous methyl donor S-adenosylmethionine (SAM) or its inactive analog S-adenosylhomocystine (SAH) as control. Treatment with SAM resulted in a dose-dependent inhibition of tumor cell proliferation, invasion, cell migration, and cell cycle characteristics. Inoculation of cells treated with 150 ?mol/L SAM for 6 days into tibia or via intravenous route into Fox Chase severe combined immune deficient (SCID) mice resulted in the development of significantly smaller skeletal lesions and a marked reduction in pulmonary metastasis as compared to control groups. Epigenome wide association studies (EWAS) showed differential methylation of several genes involved in OS progression and prominent signaling pathways implicated in bone formation, wound healing, and tumor progression in SAM-treated LM-7 cells. Real-time polymerase chain reaction (qPCR) analysis confirmed that SAM treatment blocked the expression of several prometastatic genes and additional genes identified by EWAS analysis. Immunohistochemical analysis of normal human bone and tissue array from OS patients showed significantly high levels of expression of one of the identified gene platelet-derived growth factor alpha (PDGFA). These studies provide a possible mechanism for the role of DNA demethylation in the development and metastasis of OS to provide a rationale for the use of hypermethylation therapy for OS patients and identify new targets for monitoring OS development and progression.

SUBMITTER: Parashar S 

PROVIDER: S-EPMC4430266 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.

Parashar Surabhi S   Cheishvili David D   Arakelian Ani A   Hussain Zahid Z   Tanvir Imrana I   Khan Haseeb Ahmed HA   Szyf Moshe M   Rabbani Shafaat A SA  

Cancer medicine 20150126 5


Osteosarcoma (OS) is an aggressive and highly metastatic form of primary bone cancer affecting young children and adults. Previous studies have shown that hypomethylation of critical genes is driving metastasis. Here, we examine whether hypermethylation treatment can block OS growth and pulmonary metastasis. Human OS cells LM-7 and MG-63 were treated with the ubiquitous methyl donor S-adenosylmethionine (SAM) or its inactive analog S-adenosylhomocystine (SAH) as control. Treatment with SAM resul  ...[more]

Similar Datasets

| S-EPMC5797041 | biostudies-literature
| S-EPMC8328732 | biostudies-literature
| S-EPMC5682665 | biostudies-literature
| S-EPMC9529391 | biostudies-literature
| S-EPMC8674875 | biostudies-literature
2017-04-28 | GSE98275 | GEO
| S-EPMC9425973 | biostudies-literature
2021-11-23 | GSE188952 | GEO
| S-EPMC5908115 | biostudies-literature
| S-EPMC5362503 | biostudies-literature